Saqib Islam

Saqib Islam is the Chief Executive Officer of SpringWorks Therapeutics, a biopharmaceutical company focused on developing innovative treatments for severe rare diseases and cancer, since September 2017. In addition to this role, Saqib serves as a member of the Board of Directors for Passage Bio and ARS Pharmaceuticals, Inc. Current roles also include Chief Financial Officer and Chief Business Officer at Passage Bio. Prior experience includes serving as Chief Business Officer at Moderna Therapeutics and as Executive Vice President - Chief Strategy Officer at Alexion Pharmaceuticals, Inc. Saqib held the position of Managing Director in Investment Banking at both Credit Suisse and Morgan Stanley. Educational credentials include a Doctor of Law (JD) from Columbia University and a Bachelor's degree from McGill University.